2A Pharma ApS: Financial statements 2019
CVR: 39391597
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
2A Pharma ApS (CVR 39391597) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 1,525,401 and a net result of DKK -81,364 compared with DKK -59,940 the year before. That is an increase of 61.1% compared with the year before. Equity in the 2019 report amounted to DKK 344,376. The solvency ratio was 55%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,525,401
- Profit/Loss
- DKK -81,364
- Equity
- DKK 344,376
- Total Assets
- DKK 626,003
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 1.5 mio. | -81 t. | 344 t. | 1 |
| 2018 | - | 947 t. | -60 t. | 426 t. | 1 |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
2A Pharma ApS has published its interim report for the period March 1, 2018 – December 31, 2018.
As of March 7, 2019, Preben Bruun-Nyzell is registered as adm. dir. of 2A Pharma ApS.
As of March 6, 2019, Preben Bruun-Nyzell has stepped down as director of 2A Pharma ApS.
As of March 6, 2019, Sigbjørn Georg Nielsen Kjærgård has stepped down as adm. dir. of 2A Pharma ApS.
About 2A Pharma ApS
2A Pharma ApS is a Danish company of the type Anpartsselskab based in Aalborg Øst, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Preben Bruun-Nyzell and Josephus Dirk Vestergaard Nieland. The company is owned by 2A Pharma AB. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 587,253 and a net result of DKK -712,675 compared with DKK 4,297 the year before. Equity in the 2025 report amounted to DKK 263,490.